Acyclovir-resistant herpes: expanded access available for cidofovir gel (Forvade).
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications; D000212:Acyclovir / Q000627:therapeutic use*; D000998:Antiviral Agents / Q000008:administration & dosage / Q000600:supply & distribution* / Q000627:therapeutic use; D000077404:Cidofovir; D003596:Cytosine / Q000008:administration & dosage / Q000600:supply & distribution* / Q000627:therapeutic use; D017277:Drug Approval; D005782:Gels; D006561:Herpes Simplex / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D063065:Organophosphonates; D009943:Organophosphorus Compounds / Q000008:administration & dosage / Q000600:supply & distribution* / Q000627:therapeutic use
D000998:Antiviral Agents; D005782:Gels; D063065:Organophosphonates; D009943:Organophosphorus Compounds; D003596:Cytosine; D000077404:Cidofovir; D000212:Acyclovir